Scenario · Pharmaceuticals
A pharmaceutical team's campaign materials had served several audiences without clear ownership of the evidence or next action. We defined audience roles, organized approved claims and built a production plan around the team's review process.
20 days → 14 days
60% → 75%
80 → 110
Comparable reporting periods
A pharmaceutical team's campaign materials had served several audiences without clear ownership of the evidence or next action.
The work focused on median content review cycle, first-pass content approval, completed approved stakeholder requests. These were communication and review-process measures. They established no prescribing, clinical, patient or medicine-sales outcome; request completion meant the approved information was supplied.
Which activity helped median content review cycle, and what happened at the next decision?
What we did
The priority was median content review cycle. The team used first-pass content approval and completed approved stakeholder requests to assess the next stages, with a clear distinction between activity and accepted outcomes.
We defined audience roles, organized approved claims and built a production plan around the team's review process.
The team compared median content review cycle, first-pass content approval, completed approved stakeholder requests across the agreed reporting periods. These were communication and review-process measures. They established no prescribing, clinical, patient or medicine-sales outcome; request completion meant the approved information was supplied.
Median content review cycle moved from 20 days to 14 days. First-pass content approval moved from 60% to 75%. Completed approved stakeholder requests moved from 80 to 110.
These were communication and review-process measures. They established no prescribing, clinical, patient or medicine-sales outcome; request completion meant the approved information was supplied.
We calculated relative changes from the baseline and comparison values and reported conversion or retention changes in percentage points. We rounded displayed changes to one decimal place where needed. The figures did not establish that marketing caused the outcome.
Measurement window: Two comparable quarters of approved pharmaceutical communication work.
Related reading
Pharmaceutical marketing requires distinct narratives for prescribers, patients and purchasing stakeholders. Campout helps teams structure brand positioning, content production and channel plans around approved evidence,
Most market sizing is arithmetic performed to justify a decision already made. This guide covers how to size an opportunity you can actually defend: what
Buyer interviews only change strategy when they are done properly. This is our working method: how to recruit the right people, how to design questions
Next step
If your budget conversation runs on impressions, that is the first thing we would fix.
